Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001736945-18-000006
Filing Date
2018-05-30
Accepted
2018-05-30 14:53:03
Documents
1
Effectiveness Date
2018-05-30
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 12030
  Complete submission text file 0001736945-18-000006.txt   13290
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

EIN.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-313514 | Film No.: 18867751
SIC: 2836 Biological Products, (No Diagnostic Substances)